Acne vulgaris
Conditions
Interventions
Repeated use of clear facial lotion R and milky facial lotion R for 8 weeks
Repeated use of clear facial lotion S and milky facial lotion S for 8 weeks
Sponsors
DRC Co., Ltd.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: ?Japanese females aged from 20 to less than 45 years old at the time informed consent was provided ?Subjects with mild acne vulgaris of the same degree on both the left and right of the face, and with low skin moisture as measured by a screening test ?Voluntary study participants who provided written informed consent
Exclusion criteria
Exclusion criteria: ?Subjects with moderate or greater acne vulgaris ?Subjects using oral contraceptives or oral anti-androgen drugs that affects their acne vulgaris ?Subjects receiving systemic administration of a steroid or immunosuppressive agent ?Subjects using a medical-use topical moisturizer on the face ?Subjects with allergies to cosmetics or foods ?Pregnant women, those who may be pregnant, lactating women, or women who hope to become pregnant during the study period ?Subjects who has participated in other human studies within the past four weeks, or subjects who plan to participate in other human studies during the planned period of the study ?Subjects who were considered inappropriate for the study by an investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of dermatological assessment and questionnaire before and after the repeated use of clear facial lotion and milky facial lotion for 1, 4, 6, and 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Measurement of transepidermal water loss (TEWL) and skin moisture | — |
Countries
Japan
Contacts
Public ContactMasafumi Takano
DRC Co., Ltd. Product Testing Department
Outcome results
None listed